Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buti

Showing results (51-60 of 1,279) with videos related to

Pageof 128
Sort By:
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Patient experience in HCV therapy: what really mattersMaría Buti, Rafael Esteban
The Lancet. Oncology|October 22, 2013
Axitinib dose titration: what's the limiting factor?Sebastiano Buti, Camillo Porta
The New England Journal of Medicine|December 16, 2020
Avelumab Maintenance for Urothelial CarcinomaSebastiano Buti, Melissa Bersanelli
Annals of Hepatology|November 17, 2007
Long-term outcome after interferon therapy in patients with chronic hepatitis CMaria Buti, Rafael Esteban
The Lancet Regional Health. Europe|March 19, 2025
The Italian hospital medical profession is broken tooSebastiano Buti, Giuseppe Fornarini
Physics in Medicine and Biology|July 11, 2022
Modeling the propagation of tumor fronts with shortest path and diffusion models-implications for the definition of the clinical target volumeThomas Bortfeld, Gregory Buti
The New England Journal of Medicine|February 18, 2016
Drug-Induced Megaloblastic AnemiaSebastiano Buti, Angelica Sikokis
Gastroenterology|September 30, 2015
Therapy with direct-acting antivirals for genotype 3 patients: interferon's last gasp?Rafael Esteban, Maria Buti
Acta Bio-Medica : Atenei Parmensis|May 11, 2016
Upfront Chemohormonal Therapy for Prostate Cancer: Neutropenia and G-CSF UseSebastiano Buti, Melissa Bersanelli
The Lancet. Oncology|March 15, 2016
Non-clear-cell renal carcinoma therapy: handle with careSebastiano Buti, Melissa Bersanelli
Pageof 128

Showing results (51-60 of 1,279) with videos related to

Sort By:
Pageof 128
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Patient experience in HCV therapy: what really mattersMaría Buti, Rafael Esteban
The Lancet. Oncology|October 22, 2013
Axitinib dose titration: what's the limiting factor?Sebastiano Buti, Camillo Porta
The New England Journal of Medicine|December 16, 2020
Avelumab Maintenance for Urothelial CarcinomaSebastiano Buti, Melissa Bersanelli
Annals of Hepatology|November 17, 2007
Long-term outcome after interferon therapy in patients with chronic hepatitis CMaria Buti, Rafael Esteban
The Lancet Regional Health. Europe|March 19, 2025
The Italian hospital medical profession is broken tooSebastiano Buti, Giuseppe Fornarini
Physics in Medicine and Biology|July 11, 2022
Modeling the propagation of tumor fronts with shortest path and diffusion models-implications for the definition of the clinical target volumeThomas Bortfeld, Gregory Buti
The New England Journal of Medicine|February 18, 2016
Drug-Induced Megaloblastic AnemiaSebastiano Buti, Angelica Sikokis
Gastroenterology|September 30, 2015
Therapy with direct-acting antivirals for genotype 3 patients: interferon's last gasp?Rafael Esteban, Maria Buti
Acta Bio-Medica : Atenei Parmensis|May 11, 2016
Upfront Chemohormonal Therapy for Prostate Cancer: Neutropenia and G-CSF UseSebastiano Buti, Melissa Bersanelli
The Lancet. Oncology|March 15, 2016
Non-clear-cell renal carcinoma therapy: handle with careSebastiano Buti, Melissa Bersanelli
Pageof 128